An open-label, uncontrolled long-term safety study of CP-464 005 (inhaled insulin) in Japanese patients with type 1 or type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2009
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 16 Oct 2009 Last checked against ClinicalTrials.gov record.
- 28 Aug 2008 Planned end date changed from 1 Jan 2009 to 1 Jul 2008 as reported by ClinicalTrials.gov.